AGP Executive Report
Last update: 5 hours agoMeasles Surge: U.S. cases reached 4,852, including 1,398 in Pennsylvania, where 265 people have been hospitalized. Nationally, 96% of cases were unvaccinated or had unknown vaccination status. Flu Season: Weekly flu hospitalization rates are at their highest for this point since 2010–11 and more than 10 times last year’s level, the CDC reports. Infant Nutrition: The FDA proposed the first update to formula nutrient standards since 1998, including revised requirements for iodine, manganese and vitamins A and D. Comments are open through Feb. 26, 2027. New Treatment: The FDA granted accelerated approval to Voceryq, a plasmid-based immunotherapy for adults with recurrent respiratory papillomatosis, to reduce the need for surgery. Medication Recall: Ascend recalled 11,424 bottles of amlodipine/olmesartan after tests found the tablets might not dissolve properly. Medicaid Coverage: A federal judge vacated CMS’s narrowed definition of “medically frail,” saying it could put vulnerable enrollees at risk of losing coverage. Drug Benefit Costs: A new Labor Department rule requires pharmacy benefit managers to disclose fees, rebates and other compensation to self-insured employers, who can audit the disclosures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
